TARO | Taro Pharmaceutical Industries Ltd. Stock Financials Income Statements Annual

(Stock Exchange: NYSE)

*Sign In to persist settings

Financial Year End	2024-03-31	2023-03-31	2022-03-31	2021-03-31	2020-03-31	2019-03-31	2018-03-31	2017-03-31	2016-03-31	2015-03-31	2014-03-31	2013-03-31	2012-03-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31	1998-12-31	1997-12-31	1996-12-31	1995-12-31
Revenue	629.18M	572.95M	561.35M	548.97M	644.77M	669.89M	661.91M	879.39M	950.75M	862.94M	759.30M	671.00M	145.10M	505.70M	392.50M	355.90M	327.40M	318.50M	252.30M	288.60M	271.00M	278.10M	211.60M	149.20M	103.80M	83.80M	66.70M	61.00M	56.50M	49.60M
Cost of Revenue	324.20M	304.63M	268.23M	252.31M	245.04M	224.17M	198.41M	207.86M	169.74M	186.36M	179.30M	176.10M	46.00M	176.10M	159.00M	146.90M	139.50M	128.10M	123.50M	122.60M	127.50M	102.50M	79.50M	54.70M	41.20M	35.30M	30.40M	29.30M	22.70M	19.10M
Gross Profit	304.98M	268.32M	293.12M	296.66M	399.73M	445.72M	463.51M	671.53M	781.01M	676.59M	580.00M	494.90M	99.10M	329.60M	233.50M	209.00M	187.90M	190.40M	128.80M	166.00M	143.50M	175.60M	132.10M	94.50M	62.60M	48.50M	36.30M	31.70M	33.80M	30.50M
Operating Expenses	283.47M	250.61M	168.22M	151.51M	153.19M	153.21M	158.61M	156.30M	164.50M	148.95M	149.75M	166.25M	128.01M	124.78M	144.29M	136.44M	134.07M	127.09M	145.32M	153.87M	165.24M	138.32M	78.85M	62.62M	46.49M	42.07M	34.00M	31.00M	29.00M	25.20M
Selling, General & Admin	218.94M	198.37M	113.68M	91.36M	93.41M	89.97M	88.20M	85.66M	92.36M	87.64M	91.73M	86.44M	94.56M	93.92M	107.90M	102.20M	99.03M	97.27M	109.05M	108.10M	123.30M	97.72M	52.48M	42.99M	31.90M	25.93M	20.70M	18.00M	17.70M	23.40M
Research & Development	64.54M	52.24M	54.54M	60.15M	59.78M	63.24M	70.42M	70.64M	71.16M	65.51M	55.40M	46.50M	9.80M	30.90M	36.40M	33.30M	33.70M	27.80M	36.30M	45.70M	42.00M	40.60M	26.40M	19.60M	14.60M	11.70M	9.20M	9.70M	8.90M	N/A
Other Operating Expenses	64.54M	2.46M	4.23M	2.89M	3.02M	1.81M	N/A	N/A	973.00K	-4.20M	2.62M	33.31M	23.66M	-33.00K	-7.00K	943.00K	1.34M	2.02M	-27.00K	67.00K	-57.00K	1.00K	-27.00K	33.00K	-7.00K	4.44M	4.10M	3.30M	2.40M	1.80M
Operating Income	21.51M	17.71M	184.37M	704.44M	246.53M	296.19M	303.01M	514.95M	614.47M	527.63M	430.30M	328.60M	66.20M	204.70M	86.50M	71.80M	54.20M	67.70M	-70.40M	9.50M	-28.90M	37.10M	53.30M	32.80M	16.10M	10.80M	6.50M	4.00M	4.80M	5.30M
Other Expenses / Income	61.16M	20.50M	-106.51M	-1.10B	51.50M	30.80M	-10.64M	45.85M	22.35M	54.05M	13.60M	7.30M	-1.10M	4.30M	-11.10M	-13.00M	2.20M	-20.20M	-11.40M	-7.90M	-4.80M	-2.70M	-100.00K	-2.30M	-3.50M	-3.80M	-2.80M	-2.00M	-1.50M	-1.80M
Before Tax Income	82.67M	38.21M	77.86M	-391.07M	298.04M	356.85M	292.37M	560.80M	636.82M	581.68M	443.90M	335.90M	65.10M	209.00M	75.40M	58.80M	56.40M	47.50M	-81.80M	1.60M	-33.70M	34.40M	53.20M	30.50M	12.60M	7.00M	3.70M	2.00M	3.30M	3.50M
Income Tax Expenses	28.80M	12.77M	19.59M	9.67M	53.48M	74.73M	81.95M	103.78M	95.31M	96.06M	82.70M	67.80M	17.80M	24.60M	10.50M	-69.70M	13.50M	5.50M	900.00K	1.50M	3.80M	4.10M	8.40M	4.40M	2.50M	1.50M	1.40M	600.00K	1.10M	1.50M
Net Income	53.87M	25.45M	58.27M	-400.74M	244.24M	281.78M	211.15M	456.36M	540.93M	484.26M	360.40M	266.20M	47.30M	182.70M	64.10M	114.00M	30.50M	34.30M	-82.70M	100.00K	-37.50M	30.30M	44.60M	26.00M	10.00M	5.50M	2.30M	1.40M	2.20M	2.00M
Interest Expenses	N/A	-17.69M	1.65M	1.36M	725.00K	256.00K	304.00K	131.00K	473.00K	928.00K	1.51M	2.51M	N/A	4.67M	11.84M	16.53M	795.00K	22.82M	13.69M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Basic Shares Outstanding	37.58M	37.58M	37.64M	38.21M	38.46M	38.99M	40.16M	41.30M	42.83M	42.83M	44.30M	44.70M	44.60M	44.50M	41.90M	40.60M	40.40M	35.20M	29.30M	29.60M	29.10M	29.70M	29.40M	26.30M	23.90M	21.50M	20.20M	20.80M	20.00M	20.00M
Diluted Shares Outstanding	37.58M	37.58M	37.64M	38.21M	38.46M	38.99M	40.16M	41.30M	42.83M	42.83M	44.30M	44.70M	44.60M	44.50M	41.90M	40.60M	40.40M	35.20M	29.30M	29.60M	29.10M	29.70M	29.40M	26.30M	23.90M	21.50M	20.20M	20.80M	20.95M	21.05M
EBITDA	52.60M	52.65M	210.28M	728.12M	253.08M	282.12M	309.90M	575.10M	651.57M	597.04M	461.18M	354.28M	83.72M	230.70M	105.27M	79.27M	65.98M	85.23M	-43.00M	26.88M	-14.08M	48.81M	61.40M	37.16M	18.49M	11.41M	7.80M	5.30M	5.70M	5.30M
EBITDA Margin	8.36%	9.19%	37.46%	132.63%	39.25%	42.11%	46.82%	65.40%	68.53%	69.19%	60.74%	52.80%	57.70%	45.62%	26.82%	22.27%	20.15%	26.76%	-17.04%	9.31%	-5.19%	17.55%	29.02%	24.90%	17.81%	13.62%	11.69%	8.69%	10.09%	10.69%
EBIT	82.67M	20.53M	79.51M	-389.71M	298.45M	356.76M	293.41M	560.27M	636.72M	581.24M	444.62M	336.51M	65.10M	211.97M	86.44M	60.83M	44.80M	62.62M	-68.11M	1.60M	-33.70M	34.40M	53.00M	30.40M	12.50M	7.00M	3.70M	2.00M	3.30M	3.50M
EBIT Margin	13.14%	3.58%	14.16%	-70.99%	46.29%	53.26%	44.33%	63.71%	66.97%	67.36%	58.56%	50.15%	44.87%	41.92%	22.02%	17.09%	13.68%	19.66%	-27.00%	0.55%	-12.44%	12.37%	25.05%	20.38%	12.04%	8.35%	5.55%	3.28%	5.84%	7.06%
Financial Year End	2024-03-31	2023-03-31	2022-03-31	2021-03-31	2020-03-31	2019-03-31	2018-03-31	2017-03-31	2016-03-31	2015-03-31	2014-03-31	2013-03-31	2012-03-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31	1998-12-31	1997-12-31	1996-12-31	1995-12-31